Document is current
Any future updates will be listed below
-
Authors
Yang, Xian-Yan
Chen, Nian
Wen, Qian
Zhou, Yu
Zhang, Tao
Zhou, Ji
Liang, Cheng-Hui
Han, Li-Ping
Wang, Xiao-Ya
Kang, Qing-Mei
Zheng, Xiao-Xia
Zhai, Xue-Jia
Jiang, Hong-Ying
Shen, Tian-Hua
Xiao, Jin-Wei
Zou, Yu-Xin
Deng, Yun
Lin, Shuang
Duan, Jiang-Jie
Wang, Jun
Yu, Shi-Cang
-
Funding
Funding for this research was provided by:
the National Key Research and Development Program of China (2022YFA1205000)
major research projects of the National Natural Science Foundation of China (92059204)
general research projects of the National Natural Science Foundation of China (82273419)
major projects of the Technological Innovation and Application Development Foundation in Chongqing (CSTB2022TIAD-STX0012)
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 6 December 2024
First Online: 13 January 2025
Declarations
:
: All animal experimental protocols were approved by the Ethics Committee for the Use of Experimental Animals of Army Medical University (AMUWEC20227011), and all procedures were performed under governmental and institutional guidelines and regulations. The use of two TMAs derived from the TNBC patients was granted ethical approval (XYLL-2021B001), and the study was exempted from the obligation to obtain informed consent. The Declaration of Helsinki of the World Medical Association was followed when the study was conducted.
: Written informed consent for publication was obtained from all participants.
: The authors declare that they have no competing interests.
